California biotech companies had their eye on the U.S. Supreme Court this week as it heard arguments on a key question: can you patent a human gene? The court's ruling could mean millions of dollars to biotech companies and universities.
Sponsored
upper waypoint
lower waypointnext waypoint
Stay in touch. Sign up for our daily newsletter.
To learn more about how we use your information, please read our privacy policy.